Program

9
5
1

Journal Year Published

1
1
2
2
3
1

Author

10
183
175
144
135
127
119
118
115
108
94
87
81
77
57
52
50
45
44
42
34

Category

5
4
2
1
1

Keyword

5
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1

Journal

2
2
1
1
1
1
1
1

NCATS Publications

Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.


Lin GL, et al.


Sci Transl Med , (11), 2019.

Article Pubmed

Sample image from publication page

Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.


Martin SES, Tan ZW, Itkonen HM, Duveau D, Paulo JA, Janetzko J, Boutz PL, Törk L, Moss FA, Thomas C, Gygi SP, Lazarus MB, Walker S


J. Am. Chem. Soc. , (140), 13542-13545, 2018.

Article Pubmed

Sample image from publication page

Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.


Venkatesh HS, Tam LT, Woo PJ, Lennon J, Nagaraja S, Gillespie SM, Ni J, Duveau D, Morris P, Zhao J, Thomas C, Monje M


Nature , (549), 533-537, 2017.

Article Pubmed

Sample image from publication page

Matrix Screen Identifies Synergistic Combination of PARP Inhibitors and Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors in Ewing Sarcoma.


Heske CM, Davis MI, Baumgart JT, Wilson K, Gormally MV, Chen L, Zhang X, Ceribelli M, Duveau D, Guha R, Ferrer-Alegre M, Arnaldez FI, Ji J, Tran HL, Zhang Y, Mendoza A, Helman LJ, Thomas C


Clin. Cancer Res. , 2017.

Article Pubmed

Sample image from publication page

Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.


Zhang M, Mathews Griner LA, Ju W, Duveau D, Guha R, Petrus MN, Wen B, Maeda M, Shinn P, Ferrer-Alegre M, Conlon KD, Bamford RN, O'Shea JJ, Thomas C, Waldmann TA


Proc. Natl. Acad. Sci. U.S.A. , (112), 12480-5, 2015.

Article Pubmed

A small molecule that inhibits OGT activity in cells.


Ortiz-Meoz RF, Jiang J, Lazarus MB, Orman M, Janetzko J, Fan C, Duveau D, Tan ZW, Thomas C, Walker S


ACS Chem. Biol. , (10), 1392-7, 2015.

Article Pubmed

Sample image from publication page

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells.


Mathews Griner LA, Guha R, Shinn P, Young RM, Keller JM, Liu D, Goldlust IS, Yasgar A, McKnight C, Boxer MB, Duveau D, Jiang J, Michael S, Mierzwa T, Huang W, Walsh MJ, Mott BT, Patel P, Leister W, Maloney DJ, LeClair C, Rai Bantukallu G, Jadhav A, Peyser BD, Austin C, Martin SE, Simeonov A, Ferrer-Alegre M, Staudt LM, Thomas C


Proc. Natl. Acad. Sci. U.S.A. , (111), 2349-54, 2014.

Article Pubmed

Sample image from publication page

Elucidation of the structural basis of interaction of the BCR-ABL kinase inhibitor, nilotinib (Tasigna) with the human ABC drug transporter P-glycoprotein.


Shukla S, Chufan EE, Singh S, Skoumbourdis AP, Kapoor K, Boxer MB, Duveau D, Thomas C, Talele TT, Ambudkar SV


Leukemia , (28), 961-4, 2014.

Article Pubmed

Sample image from publication page

Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors.


Duveau D, Hu X, Walsh MJ, Shukla S, Skoumbourdis AP, Boxer MB, Ambudkar SV, Shen M, Thomas C


Bioorg. Med. Chem. Lett. , (23), 682-6, 2013.

Article Pubmed

Sample image from publication page